| Patent Number |
Title Of Patent |
Date Issued |
| RE30309 |
N-Alkyl-3-pyridinium-methanol fluorides and derivatives thereof |
June 17, 1980 |
| The present invention relates to new chemical compounds which can be used as inhibitors of dental plaque, and orally-acceptable compositions thereof, combinations thereof with known compounds having an inhibitory action on the formation of dental plaque, such as biguanidines, and method |
| 5362474 |
Method for detecting and locating inflammatory or tumor foci in a patient and diagnostic kit the |
November 8, 1994 |
| The present invention relates to an aerosol composition containing a carrier agent capable of recognizing and binding to inflammatory and tumor foci mobilizing macrophages in their immediate environment, and an aerosol substrate, characterized in that the said carrier agent consists of a |
| 4937327 |
Derivative of D.25, process for its preparation, its use as an immunostimulant, and pharmaceutic |
June 26, 1990 |
| The present invention relates to a polysaccharide derivative, which is a derivative of D.25 in which the galactofuranose (Gal.sub.f) residues of the linear polysaccharide chain have been converted at least partly to arabinose.It also relates to the process for its preparation, to its use |
| 4460575 |
Vaccinal complex containing a specific antigen and vaccine containing it |
July 17, 1984 |
| The present invention relates to a vaccinal complex containing a specific antigen. This is a vaccinal complex characterized in that it is composed of bacterial ribosomal RNA or fragments of bacterial ribosomal RNA on which are coupled from 1 to 5% by weight of a specific antigen of b |
| 4397838 |
Preparations of purified bacterial membranal proteoglycans |
August 9, 1983 |
| This invention relates to a process for the preparation of purified bacterial membranal proteoglycans. The process comprises at least one step in which crude proteoglycans are treated in aqueous medium with a base or a hypobromite, followed by elimination of the excess reactant and the |
| 4349540 |
Process for preparing vaccines based on antigenic ribosomal fractions |
September 14, 1982 |
| Vaccines which comprise in association the ribosomal fraction extracted from the bacterias against which a protection is wanted, and the peptidoglycanes extracted from the membranes of at least one of the bacteria previously used. |
| 4297272 |
Process for the preparation of purified bacterial membranal proteoglycans |
October 27, 1981 |
| This invention relates to a process for the preparation of purified bacterial membranal proteoglycans. The process comprises at least one step in which crude proteoglycans are treated in aqueous medium with a base or a hypobromite, followed by elimination of the excess reactant and the |
